1. Home
  2. MDXH vs GHI Comparison

MDXH vs GHI Comparison

Compare MDXH & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$3.82

Market Cap

183.4M

Sector

N/A

ML Signal

HOLD

Logo Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

GHI

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

HOLD

Current Price

$7.73

Market Cap

161.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDXH
GHI
Founded
2003
1998
Country
Belgium
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
183.4M
161.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
MDXH
GHI
Price
$3.82
$7.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$7.67
$13.00
AVG Volume (30 Days)
151.4K
156.2K
Earning Date
02-26-2026
02-19-2026
Dividend Yield
N/A
19.27%
EPS Growth
N/A
N/A
EPS
N/A
0.17
Revenue
$103,069,000.00
$26,247,399.00
Revenue This Year
$23.34
$201.02
Revenue Next Year
$22.98
$2.87
P/E Ratio
N/A
$45.52
Revenue Growth
21.68
N/A
52 Week Low
$1.35
$6.01
52 Week High
$5.33
$13.29

Technical Indicators

Market Signals
Indicator
MDXH
GHI
Relative Strength Index (RSI) 55.75 54.39
Support Level $3.56 $7.63
Resistance Level $4.34 $8.11
Average True Range (ATR) 0.27 0.33
MACD 0.07 0.04
Stochastic Oscillator 61.19 63.00

Price Performance

Historical Comparison
MDXH
GHI

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

Share on Social Networks: